Aspen Aerogels (NYSE:ASPN) reported quarterly losses of $(0.28) per share which missed the analyst consensus estimate of $(0.26) by 7.69 percent. This is a 366.67 percent decrease over losses of $(0.06) per share from the same period last year. The company reported quarterly sales of $37.884 million which beat the analyst consensus estimate of $37.388 million by 1.33 percent. This is a 51.88 percent decrease over sales of $78.723 million the same period last year.